Related Experiment Video
Updated: Apr 1, 2026

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
Published on: July 18, 2019
The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome
Claire L Mellor1, Fabian P Steinmetz1, Mark T D Cronin1
1a School of Pharmacy and Biomolecular Sciences , Liverpool John Moores University , Liverpool , England.
Abstract:
The development of adverse outcome pathways (AOPs) is becoming a key component of twenty-first century toxicology. AOPs provide a conceptual framework that links the molecular initiating event to an adverse outcome through organized toxicological knowledge, bridging the gap from chemistry to toxicological effect. As nuclear receptors (NRs) play essential roles for many physiological processes within the body, they are used regularly as drug targets for therapies to treat many diseases including diabetes, cancer and neurodegenerative diseases. Due to the heightened development of NR ligands, there is increased need for the identification of related AOPs to facilitate their risk assessment. Many NR ligands have been linked specifically to steatosis. This article reviews and summarizes the role of NR and their importance with links between NR examined to identify plausible putative AOPs. The following NRs are shown to induce hepatic steatosis upon ligand binding: aryl hydrocarbon receptor, constitutive androstane receptor, oestrogen receptor, glucocorticoid receptor, farnesoid X receptor, liver X receptor, peroxisome proliferator-activated receptor, pregnane X receptor and the retinoic acid receptor. A preliminary, putative AOP was formed for NR binding linked to hepatic steatosis as the adverse outcome.
Insights
Nuclear receptors (NRs) are crucial drug targets. This review identifies adverse outcome pathways (AOPs) linking NR ligand binding to hepatic steatosis, aiding toxicological risk assessment.
Area of Science:
- Toxicology
- Endocrinology
- Molecular Biology
Background:
- Adverse Outcome Pathways (AOPs) are essential frameworks in modern toxicology.
- Nuclear Receptors (NRs) are key drug targets for diseases like diabetes and cancer.
- Increased development of NR ligands necessitates AOP identification for risk assessment.
Purpose of the Study:
- To review and summarize the role of NRs in toxicology.
- To identify plausible AOPs linking NR ligand binding to adverse outcomes.
- To specifically examine NR-induced hepatic steatosis.
Main Methods:
- Literature review and synthesis of existing toxicological knowledge.
- Examination of established links between NR activation and biological effects.
- Identification of commonalities and patterns in NR-mediated toxicity.
Main Results:
- Several NRs, including aryl hydrocarbon receptor, constitutive androstane receptor, and others, are implicated in inducing hepatic steatosis upon ligand binding.
- A preliminary, putative AOP framework was developed for NR binding leading to hepatic steatosis.
- The study highlights the importance of NRs in toxicological pathways.
Conclusions:
- NRs play a significant role in the development of hepatic steatosis.
- Understanding NR-mediated AOPs is critical for drug development and risk assessment.
- Further research into NR-specific AOPs will enhance toxicological evaluations.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenomics: Identification of New Drug Targets
Signal Transduction: Overview
Typically, signal transduction involves three...
Regulation of Nuclear Protein Sorting
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

